Evoked potentials and neuropsychological tests validate Positron Emission Topography (PET) brain metabolism in cognitively impaired patientsSex, drugs, and rock 'n' roll: hypothesizing common mesolimbic activation as a function of reward gene polymorphismsNeurogenetic interactions and aberrant behavioral co-morbidity of attention deficit hyperactivity disorder (ADHD): dispelling myths.Hypersexuality Addiction and Withdrawal: Phenomenology, Neurogenetics and EpigeneticsHypersexuality Addiction and Withdrawal: Phenomenology, Neurogenetics and EpigeneticsDopamine and glucose, obesity, and reward deficiency syndromeNeuropsychopharmacology and neurogenetic aspects of executive functioning: should reward gene polymorphisms constitute a diagnostic tool to identify individuals at risk for impaired judgment?Low dopamine function in attention deficit/hyperactivity disorder: should genotyping signify early diagnosis in children?Exoproteome and secretome derived broad spectrum novel drug and vaccine candidates in Vibrio cholerae targeted by Piper betel derived compoundsSystematic evaluation of "compliance" to prescribed treatment medications and "abstinence" from psychoactive drug abuse in chemical dependence programs: data from the comprehensive analysis of reported drugsGenetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS)Generational association studies of dopaminergic genes in reward deficiency syndrome (RDS) subjects: selecting appropriate phenotypes for reward dependence behaviorsEnhanced functional connectivity and volume between cognitive and reward centers of naïve rodent brain produced by pro-dopaminergic agent KB220Z.Introducing Precision Addiction Management of Reward Deficiency Syndrome, the Construct That Underpins All Addictive BehaviorsNeuropharmacological and Neurogenetic Correlates of Opioid Use Disorder (OUD) As A Function of Ethnicity: Relevance to Precision Addiction MedicineUnderstanding the Scientific Basis of Post-traumatic Stress Disorder (PTSD): Precision Behavioral Management Overrides Stigmatization
P50
Q21559700-C46073D5-B8E0-4660-91CA-787B26AD1AE5Q22248047-7A61621D-9988-4DBD-8F7F-9CD7F77E2D86Q25257593-A7ABE52E-2646-4504-90F2-F4D1D608FB46Q26775668-2A6DC2B6-F669-401E-A622-A4A81C9A1263Q26801213-9CF9202F-3D5B-4BDD-9FFA-C60D840784B2Q27003334-83B6D029-BEE0-4785-B826-4B41AD1EFBADQ27024858-A0EDBB7D-5D6D-4621-B042-690A8167F70AQ27026214-91416ADA-3446-416C-A54A-8618888D428CQ28485375-08B96E16-2887-427B-9ADE-D9A71F4FB46AQ28543157-64495CF0-A63C-4546-9A93-CFC917AE4C0FQ28652508-73001E64-68B9-4F97-964C-2E1C1E1B52B0Q28731615-07B3A13C-2712-4348-B3BB-383B44307854Q33605694-E8E897BD-9705-4C21-B772-607C22340E5AQ59807426-25A6DA8B-A76B-48F3-91CA-3E0F1B401DE4Q91342486-2102A344-AA99-4623-81E5-5ECDEC31F449Q92261277-0A92FDC9-2FCC-4B29-A524-11306D3E3B9A
P50
description
American researcher
@en
geneticus
@nl
rexercor american
@lfn
name
Kenneth Blum
@ast
Kenneth Blum
@de
Kenneth Blum
@en
Kenneth Blum
@es
Kenneth Blum
@fr
Kenneth Blum
@it
Kenneth Blum
@nl
کنث بلوم
@fa
type
label
Kenneth Blum
@ast
Kenneth Blum
@de
Kenneth Blum
@en
Kenneth Blum
@es
Kenneth Blum
@fr
Kenneth Blum
@it
Kenneth Blum
@nl
کنث بلوم
@fa
altLabel
Ken Blum
@en
prefLabel
Kenneth Blum
@ast
Kenneth Blum
@de
Kenneth Blum
@en
Kenneth Blum
@es
Kenneth Blum
@fr
Kenneth Blum
@it
Kenneth Blum
@nl
کنث بلوم
@fa
P106
P1006
P1015
P214
P244
P269
P1006
P1015
P1153
35433478500
P1412
P21
P213
0000 0000 8456 0304
P214
P244
P269
P31
P496
0000-0001-6727-803X
P569
1939-08-08T00:00:00Z
P734
P735
P7859
lccn-n80158880